Cell Therapeutics

Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
Yahoo/PR NewsWire
Sat, 06/18/11 - 10:17 am
Cell Therapeutics
Investors Need a Peephole Into FDA Offices
Motley Fool
Thu, 06/16/11 - 11:12 am
investors
FDA
pixantrone
Cell Therapeutics
non-Hodgkin's lymphoma
Cell Therapeutics meets with FDA
Bizjournals.com
Tue, 06/14/11 - 10:15 am
FDA
Cell Therapeutics
What Kind of Phase 2 Drug Can You Get for $5 Million?
Motley Fool
Sat, 05/28/11 - 12:06 pm
Cell Therapeutics
Cell Therapeutics-FDA set early June pixantrone meeting
bizjournals.com
Sat, 05/21/11 - 10:41 am
Cell Therapeutics
pixantrone
PIX301
cancer
FDA Sets Meeting Date in Early June to Discuss Re-submission of Pixantrone NDA for Accelerated Approval
Yahoo
Fri, 05/20/11 - 09:47 am
FDA
pixantrone
Cell Therapeutics
non-Hodgkin's lymphoma
Cell Therapeutics: Denied but Not Rejected
Motley Fool
Wed, 05/4/11 - 08:50 pm
Cell Therapeutics
pixantrone
FDA
Cell Therapeutics gets pixantrone news from FDA office
Bizjournals.com
Tue, 05/3/11 - 11:28 am
FDA
Cell Therapeutics
pixantrone
Loss Widens at Cell Therapeutics
Yahoo/Zacks.com
Mon, 05/2/11 - 12:36 pm
earnings
Cell Therapeutics
Coronations for New Drug Royalty
Motley Fool
Sat, 04/30/11 - 09:49 am
Vertex Pharmaceuticals
Cell Therapeutics
Telaprevir
hepatitis C
Biotech Stock Mailbag: Bio-Hazards
The Street
Sat, 03/26/11 - 10:00 am
Telik
Xoma
Genta
Cell Therapeutics
Discovery Labs
Cel-Sci
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
ASCO
Medivation
Exelixis
Dendreon
Bristol-Myers Squibb
Roche
Curis
Celgene
Sanofi
Ariad Pharmaceuticals
Merck
Incyte
Novartis
YM BioSciences
Pfizer
Aveo Pharmaceutical
ONYX Pharmaceuticals
Amgen
Synta
Vical
Oxigene
Cell Therapeutics
Oncothyreon
FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone
Yahoo
Thu, 03/3/11 - 08:50 am
FDA
Cell Therapeutics
pixantrone
Biotech Calendar: Key Dates for March
TheStreet.com
Wed, 03/2/11 - 11:59 am
Human Genome Sciences
Dendreon
Cell Therapeutics
AP Pharma
Bristol-Myers Squibb
Celgene
Corcept Therapeutics
Achillion
Biotech Mailbag: BIO CEO Wrap
TheStreet.com
Fri, 02/18/11 - 09:36 am
BIO CEO Conference
Rexahn
Nymox
MannKind
Teva Pharmaceuticals
Somaxon
Medivation
Cell Therapeutics
YM BioSciences
Value Investing, Biotech Style
Motley Fool
Sat, 01/29/11 - 11:35 am
investors
Benlysta
Human Genome Sciences
GSK
Cell Therapeutics
obesity. Orexigen Therapeutics
Vertex Pharmaceuticals
Exelixis
Smart Money's 9 Top Biotech Stock Picks
Seeking Alpha
Mon, 01/17/11 - 12:53 pm
biotech
Cadence Pharmaceuticals
Cell Therapeutics
Enzon
Geron
Exelixis
Seattle Genetics
Savient
Vivus
Theravance
Cell Therapeutics raises $25M
Bizjournals.com
Thu, 01/13/11 - 01:18 pm
Cell Therapeutics
stock offering
Aastrom Biosciences' Uptrend Fueled by More Than Just Market Momentum
Seeking Alpha
Wed, 12/29/10 - 10:53 am
Aastrom
Cell Therapeutics
StemCells
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir

Pages